Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
ConditionLung Transplant Rejection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Alberta
About this trial
Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
Eligibility criteria
Qualifiers
All lung transplant recipients undergoing a biopsy as determined by their surgeon or physician.
Disqualifiers
Patients who declined participation or unable to give informed consent.
Trial design
Treatments tested in this trial
- Lung transplant biopsy bites.
Treatment groups
No treatment groups listed
Locations
11Australia
The Alfred Hospital, Monash University Melbourne Australia
Austria
Department of Thoracic Surgery, Medical University of Vienna Vienna Austria
Canada
Alberta Transplant Applied Genomics Centre, University of AlbertaT6G 2E1, EdmontonAlberta, Canada
Department of Medicine, University of AlbertaT6G 2G3, EdmontonAlberta, Canada
Sponsors and collaborators
University of Alberta
Lead sponsor
Source ClinicalTrials.gov